about
Anomeric specificity and protein-substrate interactions support the 3D model for the hemagglutinin-neuraminidase from sendai virus.Effects of two different strategies of fluid administration on inflammatory mediators, plasma electrolytes and acid/base disorders in patients undergoing major abdominal surgery: a randomized double blind study.Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies.Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment.Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy.Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis PatientsVaginal Lactoferrin Modulates PGE2, MMP-9, MMP-2, and TIMP-1 Amniotic Fluid Concentrations.Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro studyMatrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding.Mutual relationship between serum ferroxidase activity and hemoglobin levels in elderly individuals.Characterization of anti-coagulant properties of prenylated coumarin ferulenol.N-acetylaspartate and neurofilaments as biomarkers of axonal damage in patients with progressive forms of multiple sclerosis.Long-term expression of highly differentiated functions by isolated porcine hepatocytes perfused in a radial-flow bioreactor.Peptides derived from the heptad repeat region near the C-terminal of Sendai virus F protein bind the hemagglutinin-neuraminidase ectodomain.Selective modification of Sendai virus hemagglutinin neuraminidase by pyridoxal 5'-phosphate: evidence for an allosteric modulation of neuraminidase activity.Inhibition of Sendai virus hemagglutinin neuraminidase by the fusion protein.Effects of anticoagulants on the activity of gelatinases.Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis.Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study.Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients.The active site of 6-phosphogluconate dehydrogenase. A phosphate binding site and its surroundingsMyelin basic protein inhibits the calcium response to phytohaemagglutinin in human lymphocytesEffect of 17 beta-estradiol on calcium response to phytohaemagglutinin in human lymphocytesMyelin basic protein inhibits formyl-peptide induced chemotaxis in human neutrophilsSubstrate-induced intramolecular proton transfer in 6-phosphogluconate dehydrogenase from Candida utilisThermal stabilities of lupin seed conglutin gamma protomers and tetramersMatrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategiesMatrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategiesMatrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms
P50
Q30580877-95DDFE0C-504A-4C05-A20A-CC4DD2F98C5FQ33589199-DE03EA79-D09C-4E44-9C00-E682903B46BEQ34515198-7F4A8100-0965-4B72-B3FB-03893CBCEF3FQ35697927-446DEF69-4FD9-4F53-9DBF-E72F07491604Q37009992-242B9CB0-68E3-4961-8EDA-AE18EB09D893Q37171985-9AF7BCEA-CB41-46B0-BF77-CB5E8E91A787Q37411630-9AC4F8CF-652F-439B-ABA7-162845BC3225Q38712559-D3D5F021-1896-4FB8-A3FA-BB9B88C56097Q39143880-F5359BC2-D857-4DF5-8591-F1850788E0F8Q39729695-E9700622-F658-4B5D-85B1-319BE1E2D5BEQ40095258-245B097D-6D21-4949-8D41-86F5BB012D1AQ42683530-EC671E8E-EC3C-47BE-B220-D869CF1C13B6Q43808445-CCCF923C-9A22-4022-AF2E-8C962930291BQ45729147-F15CCE0D-F528-4CFC-BAEE-E9C40A3BF043Q45775753-5AC2556C-DE06-442E-ABC6-DDA52D7FBB27Q45781655-32CEA001-4886-4AFB-ACF3-AD03E74E38A9Q46975270-C16EA3AF-D96E-4C42-A2DB-1735FD6EC852Q50773267-C9EDF03D-A9C5-4102-BD6B-7C34AF5393C8Q50853367-11624FFF-5B72-4D1E-B0B9-BA813ACD3A55Q50863436-931CD648-4800-4E65-BEEB-23DD9B92C0B0Q67016762-6F5B57E7-5E47-4B22-8768-1080A99F8A1CQ67659162-5ADF787E-8896-42D2-838F-521D83E1BD00Q68460158-AF4EEE7F-95B0-4112-B678-E41FE085E6B7Q68982479-D77791C1-6DBF-414F-B5A9-78F3BD3FDC51Q72914228-9C64CEC9-ED8B-4BC0-A6BD-AA478A0DB931Q73699089-124DC4CA-EF71-4029-87E0-6AD285E6A40FQ80226497-1A6DE4C5-1B9A-4157-97EE-05FD605F0AE9Q80577139-AB0D6E9E-D91B-450B-B75B-75B2817FE16DQ83463129-CDC05486-FC71-4870-BA7D-FA921993A678
P50
description
researcher ORCID ID = 0000-0001-7975-921X
@en
wetenschapper
@nl
name
Tiziana Bellini
@ast
Tiziana Bellini
@en
Tiziana Bellini
@es
Tiziana Bellini
@nl
type
label
Tiziana Bellini
@ast
Tiziana Bellini
@en
Tiziana Bellini
@es
Tiziana Bellini
@nl
prefLabel
Tiziana Bellini
@ast
Tiziana Bellini
@en
Tiziana Bellini
@es
Tiziana Bellini
@nl
P106
P1153
7004337741
P31
P496
0000-0001-7975-921X